Page last updated: 2024-12-08
pentafluorophenylmethacrylate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
pentafluorophenylmethacrylate: copolymerized with methylmethacrylate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 193480 |
| SCHEMBL ID | 93927 |
| MeSH ID | M0108953 |
Synonyms (31)
| Synonym |
|---|
| AKOS015837635 |
| pentafluorophenylmethacrylate |
| pentafluorophenyl methacrylate |
| 13642-97-2 |
| (2,3,4,5,6-pentafluorophenyl) 2-methylprop-2-enoate |
| 2,3,4,5,6-pentafluorophenyl 2-methylprop-2-enoate |
| pentafluorophenyl 2-methylprop-2-enoate |
| FT-0676871 |
| 2-propenoic acid, 2-methyl-, pentafluorophenyl ester |
| pentafluorophenyl-methacrylate |
| SCHEMBL93927 |
| 2-methylpropenoic acid, pentafluorophenyl ester |
| 2,3,4,5,6-pentafluorophenyl 2-methylacrylate |
| NIJWSVFNELSKMF-UHFFFAOYSA-N |
| methacrylic acid pentafluorophenyl ester |
| P2289 |
| DTXSID00159784 |
| pentafluorophenyl methacrylate, contains mehq as inhibitor, 95% |
| mfcd00042332 |
| pentafluorophenyl methacrylate (stabilized with mehq) |
| pentafluorophenyl methacrylate, >/=97%,stabilized with mehq |
| J-006844 |
| BBL101899 |
| pentafluorophenyl methacrylate,95% |
| STL555696 |
| perfluorophenyl methacrylate |
| MS-20318 |
| D92198 |
| 2-propenoic acid, 2-methyl-, 2,3,4,5,6-pentafluorophenyl ester |
| CS-0121520 |
| 111886-03-4 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (13)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 11 (84.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.48
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.48) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 13 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||